Regular Article
Significance of Coexpression of Urokinase-type Plasminogen Activator, and Matrix Metalloproteinase 3 (Stromelysin) and 9 (Gelatinase B) in Colorectal Carcinoma

https://doi.org/10.1006/jsre.2000.5952Get rights and content

Abstract

Our previous study showed that proMMP-9 was activated by MMP-3 directly, and that proMMP-3 was activated by plasmin. It was postulated that the proMMP-9 activation mechanism through the protease–protease cascade existed even in vivo. The purpose of the present study was to clarify the clinical significance of the combined expression of MMP-9, MMP-3, and urokinase-type plasminogen activator (uPA) in colorectal cancer, and the role of MMP-3 or uPA expression as an activator for MMP-9. The expression of both MMP-9 and uPA was found to be correlated with liver metastasis, and with survival rate. The coexpression of MMP-9 and uPA by tumor cells was also significantly correlated with postoperative hepatic recurrence and survival rate. MMP-9 tended to be coexpressed with uPA, and was consistently associated with MMP-3 localized at the tumor-invasive front with inflammatory cells such as monocyte-macrophages. In gelatin zymography, the MMP-9 active form tended to be identified in the tumors that coexpressed both MMP-9 and uPA. We concluded that coexpression of MMP-9 and uPA in tumor tissues might be a useful predictive factor for postoperative survival and hepatic metastasis. The following activation mechanism for proteinase might occur: uPA coexpressed with MMP-9 activated plasminogen, and plasmin activated proMMP-3, which was secreted depending upon inflammatory infiltration, and then MMP-3 activated proMMP-9, resulting in colorectal cancer progression and metastasis.

References (33)

  • M.E. Stearns et al.

    TypeIV collagenase (Mr 72,000) expression in human prostate: Benign and malignant tissue

    Cancer Res.

    (1993)
  • C. Pyke et al.

    Messenger RNA for two typeIV collagenases is located in stromal cells in human colon cancer

    Am. J. Pathol.

    (1993)
  • W.G. Stetler-Stevenson

    TypeIV collagenases in tumor invasion and metastasis

    Cancer Metastasis Rev.

    (1990)
  • L.A. Liotta et al.

    Metalloproteinases and cancer invasion

    Semin. Cancer Biol.

    (1990)
  • W.F. Grigioni et al.

    Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane

    Mod. Pathol.

    (1994)
  • M. Mori et al.

    Overexpression of matrix metalloproteinse-7 mRNA in human colon carcinomas

    Cancer

    (1995)
  • Cited by (42)

    • Expression and activation of proteases in co-cultures

      2011, Experimental and Toxicologic Pathology
    • Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells - Associations with histopathology and patients outcome

      2010, European Journal of Cancer
      Citation Excerpt :

      Matrix metalloproteinase 9 (MMP-9), also termed gelatinase B or the 92-kDa type IV collagenase, is an extracellular protease that specifically degrades collagen type IV, which is the major structural component of basement membranes.13 MMP-9 is particularly important in the context of cancer, as it allows cancer cells to infiltrate the adjacent stromal compartment, thereby facilitating a critical early step in the metastatic cascade.2,4–6,9,11,12,14,16–19 Moreover MMP-9 activates various growth factors and angiogenesis inhibitors like angiostatin with significance to tumour progression indicating a role as a general molecular switch in the microenvironment.20

    • Selected Cytokines and Metalloproteinases in Inflammatory Bowel Disease

      2024, International Journal of Molecular Sciences
    View all citing articles on Scopus
    1

    To whom correspondence should be addressed at Department of Surgery, Kurume University School of Medicine, 67 Asahi machi, Kurume City, Fukuoka 830-0011, Japan. Fax: 81-942-34-0709. E-mail:[email protected].

    View full text